Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
All Children's Hospital
mi
from
Saint Petersburg, FL
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
The Mayo Clinic
mi
from
Rochester, MN
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated:  3/21/2016
Royal Childrens Hospital
mi
from
Herston,
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Status: Enrolling
Updated: 3/21/2016
Royal Childrens Hospital
mi
from
Herston,
Click here to add this to my saved trials
Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Phase II Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Status: Enrolling
Updated:  3/21/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Phase II Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Status: Enrolling
Updated: 3/21/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Bortezomib With Melphalan and Prednisone for Multiple Myeloma
A Prospective Study of Bortezomib in Combination With Melphalan and Prednisone for Patients With Previously Untreated Multiple Myeloma
Status: Enrolling
Updated:  3/21/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Bortezomib With Melphalan and Prednisone for Multiple Myeloma
A Prospective Study of Bortezomib in Combination With Melphalan and Prednisone for Patients With Previously Untreated Multiple Myeloma
Status: Enrolling
Updated: 3/21/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Huntsville, AL
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Mobile, AL
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Mobile, AL
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Jonesboro, AR
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Duarte, CA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Duarte, CA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative site
mi
from
Los Angeles, CA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
San Francisco, CA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Miami, FL
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Atlanta, GA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Savannah, GA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Savannah, GA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Peoria, IL
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Peoria, IL
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
New Orleans, LA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative site
mi
from
Boston, MA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Detroit, MI
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Brunsville, MN
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Brunsville, MN
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigator Site
mi
from
Albuquerque, NM
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigator Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis
mi
from
New York, NY
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Cleveland, OH
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis
mi
from
Portland, OR
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Lubbock, TX
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Lubbock, TX
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Arlington, VA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Arlington, VA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Seattle, WA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Tacoma, WA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated:  3/22/2016
Novartis Investigative Site
mi
from
Vancouver, WA
EXTEND (Eltrombopag Extended Dosing Study)
EXTEND (Eltrombopag Extended Dosing Study): An Extension Study of Eltrombopag Olamine (SB-497115-GR) in Adults, With Idiopathic Thrombocytopenic Purpura (ITP), Previously Enrolled in an Eltrombopag Study.
Status: Enrolling
Updated: 3/22/2016
Novartis Investigative Site
mi
from
Vancouver, WA
Click here to add this to my saved trials
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Phase II Trial Evaluating the Safety and Efficacy of Rituximab as Primary Treatment for Extensive Chronic Graft Versus Host Disease
Status: Enrolling
Updated:  3/22/2016
Northside Hospital
mi
from
Atlanta, GA
Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Phase II Trial Evaluating the Safety and Efficacy of Rituximab as Primary Treatment for Extensive Chronic Graft Versus Host Disease
Status: Enrolling
Updated: 3/22/2016
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
A Pilot Study to Evaluate the Safety and Preliminary Evidence of a Therapeutic Effect of ODSH (2-0, 3-0, Desulfated Heparin) in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
Status: Enrolling
Updated:  3/22/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
A Pilot Study to Evaluate the Safety and Preliminary Evidence of a Therapeutic Effect of ODSH (2-0, 3-0, Desulfated Heparin) in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/22/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Genesis Cancer Center
mi
from
Hot Springs, AR
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Genesis Cancer Center
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
UCLA
mi
from
Los Angeles, CA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
St. Joseph Heritage Healthcare
mi
from
Santa Rosa, CA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
St. Joseph Heritage Healthcare
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Florida Cancer Specialists
mi
from
Fort Myers, FL
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Crescent City Research Consortium, LLC
mi
from
Marrero, LA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Crescent City Research Consortium, LLC
mi
from
Marrero, LA
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Massachusetts General Hospital
mi
from
Boston, MA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Forrest General Cancer Center
mi
from
Hattiesburg, MS
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Forrest General Cancer Center
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Nebraska Cancer Specialists
mi
from
Omaha, NE
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Nebraska Cancer Specialists
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Memorial Sloan-Kettering
mi
from
New York, NY
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Memorial Sloan-Kettering
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Levine Cancer Institute
mi
from
Charlotte, NC
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Oncology and Hematology Care Inc - Blue Ash
mi
from
Cincinnati, OH
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Oncology and Hematology Care Inc - Blue Ash
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Cleveland Clinic
mi
from
Cleveland, OH
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Ohio State University
mi
from
Columbus, OH
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Prairie Lakes Health Care System
mi
from
Watertown, SD
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Prairie Lakes Health Care System
mi
from
Watertown, SD
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Simmons Cancer Center - UT Southwestern Medical Center
mi
from
Dallas, TX
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Simmons Cancer Center - UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated:  3/22/2016
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
Status: Enrolling
Updated: 3/22/2016
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials